| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/25/2007 | WO2007011284A1 Therapeutic agents |
| 01/25/2007 | WO2007011232A2 Lipid lowering agents for increasing bmd |
| 01/25/2007 | WO2007011231A2 Use of compounds comprising fatty acid entities |
| 01/25/2007 | WO2007011072A1 Premature ovulation preventive agent |
| 01/25/2007 | WO2007011066A1 Fibroblast activator, collagen production promoter, collagen contraction promoter, hyaluronic acid production promoter, atp production promoter, melanin formation inhibitor, and agent for external application to the skin |
| 01/25/2007 | WO2007011056A1 Pyrazole compounds and thrombopoietin receptor activators |
| 01/25/2007 | WO2007011018A1 Rapidly disintegratable oral tablet |
| 01/25/2007 | WO2007010999A1 Animal in which lipid metabolism and sugar metabolism are modified by krap gene mutation, modification method and modifying agent |
| 01/25/2007 | WO2007010976A1 Body weight gain inhibitory composition comprising d-psicose and use thereof |
| 01/25/2007 | WO2007010975A1 Use of psicose in agent for prevention of the increase in blood d-fructose level |
| 01/25/2007 | WO2007010974A1 Use of antihypergycemic effect of d-allose |
| 01/25/2007 | WO2007010973A1 Utilization of anti-neuropathic pain effect of d-allose and d-psicose |
| 01/25/2007 | WO2007010965A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 01/25/2007 | WO2007010964A1 Indole derivative having pgd2 receptor antagonist activity |
| 01/25/2007 | WO2007010946A1 Synovial cell proliferation inhibitor |
| 01/25/2007 | WO2007010911A1 Agent for relieving wound and promoting wound recovery |
| 01/25/2007 | WO2007010910A1 1-benzyl-4-[(5, 6-dimethoxy-1-indanon)-2-yl]-methyl piperidine p-toluenesulfonate or crystal thereof |
| 01/25/2007 | WO2007010885A1 Substituted propanamide derivative and pharmaceutical composition containing the same |
| 01/25/2007 | WO2007010853A1 Method for control of electroporation apparatus |
| 01/25/2007 | WO2007010847A1 Sustained release preparation |
| 01/25/2007 | WO2007010846A1 Preparation having gastric residence capability |
| 01/25/2007 | WO2007010723A1 Tryptophan derivative and use thereof |
| 01/25/2007 | WO2007010628A1 Prophylactic/therapeutic agent for cancer |
| 01/25/2007 | WO2007010557A2 Process for the preparation of highly pure ropinirole |
| 01/25/2007 | WO2007010554A2 A system for mounting feeder over a rotating die-table of tablet press and method thereof |
| 01/25/2007 | WO2007010546A1 Compounds for treatment of lipase-mediated diseases |
| 01/25/2007 | WO2007010515A1 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation |
| 01/25/2007 | WO2007010504A2 Acid addition salts of isoindoles acting as adrenergic receptor antagonists |
| 01/25/2007 | WO2007010501A2 A pharmaceutical composition comprising a combination of beta blocker and an ace inhibitor |
| 01/25/2007 | WO2007010499A2 Derivatives of monosaccharides for the treatment of copd and allergic rhinitis |
| 01/25/2007 | WO2007010390A1 Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| 01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
| 01/25/2007 | WO2007010337A2 Use of phosphodiesterase type 5 inhibitors for the prevention and treatment of diseases or health disorders and dispensing system for said inhibitors |
| 01/25/2007 | WO2007010312A2 Use of mmp inhibitors for the preparation of pharmaceutical compositions of cardioprotective effect |
| 01/25/2007 | WO2007010307A1 Antineoplastic compounds |
| 01/25/2007 | WO2007010283A1 Serine beta-lactamase-like / d-ala carboxypeptidase-like protein |
| 01/25/2007 | WO2007010275A1 Novel epilepsy treatment |
| 01/25/2007 | WO2007010266A1 Pyrrolidine compositions |
| 01/25/2007 | WO2007010242A1 Use of a noradrenergic agonist, e.g. guanfacine, for the treatment of cognitive disorders |
| 01/25/2007 | WO2007010235A1 Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl] phenyl) pyridine-3- sulphonamide |
| 01/25/2007 | WO2007010216A1 Lycopene formulations for the treatment of atherosclerotic conditions |
| 01/25/2007 | WO2007010144A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof |
| 01/25/2007 | WO2007010084A2 Immunostimulatory oligo- and polysaccharides and uses thereof |
| 01/25/2007 | WO2007010044A1 3-indolylmethylene derivatives with cytostatic action |
| 01/25/2007 | WO2007010032A2 Intermolecular association complex of a carrier, preferably an n-alkylamino -1-desoxylactitol and of an active ingredient |
| 01/25/2007 | WO2007010013A2 Combination comprising a pyrimidylaminobenzamides and a flt-3 inhibitor for treating proliferative diseases |
| 01/25/2007 | WO2007010012A2 Combination of a pyrimidylaminobenzamide and an mtor kinase inhibitor |
| 01/25/2007 | WO2007009959A1 Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders |
| 01/25/2007 | WO2007009913A1 Pyridazinone derivatives as thyroid hormone receptor agonists |
| 01/25/2007 | WO2007009911A1 PYRIDO [2 , 3-D] PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS |
| 01/25/2007 | WO2007009906A1 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as v1a receptor antagonists |
| 01/25/2007 | WO2007009898A1 1h-thieno[2,3-c]pyrazole compounds useful as kinase inhibitors |
| 01/25/2007 | WO2007009897A1 Biologically active compounds obtainable from sorangium cellulosum |
| 01/25/2007 | WO2007009883A1 Novel heteroaryl fused cyclic amines |
| 01/25/2007 | WO2007009819A1 Acylglycerophospholipids for treating symptoms concomitant with cancer |
| 01/25/2007 | WO2007009806A2 Solid dosage formulations of narcotic drugs having improved buccal adsorption |
| 01/25/2007 | WO2007009801A2 Oral, quickly disintegrating film, which cannot be spit out, for a neuroleptic drug |
| 01/25/2007 | WO2007009800A2 Oral, quickly disintegrating film, which cannot be spit out, for an antiemetic or antimigraine agent |
| 01/25/2007 | WO2007009799A1 Amino acid salts of rosiglitazone |
| 01/25/2007 | WO2007009794A1 HCl POLYMORPHS OF 3 -(2-(DIMETHYLAMINO)METHYL(CYCLOHEX-1-YL))PHENOL |
| 01/25/2007 | WO2007009793A1 Salt of fumaric acid and 3-(2-dimethylamino)methyl(cyclohex-1-yl))phenol and its crystalline forms |
| 01/25/2007 | WO2007009792A1 3-(2-(dimethylamino)methyl(cyclohex-1-yl))phenol maleate and its crystalline forms |
| 01/25/2007 | WO2007009788A1 A process and composition for making olanzapine form (i) |
| 01/25/2007 | WO2007009778A1 Piperidine carboxamide derivate suitable as tachykinin receptor antagonist |
| 01/25/2007 | WO2007009777A1 Chemical compounds |
| 01/25/2007 | WO2007009776A1 Process for preparing uronic acid oligosaccharides by extrusion |
| 01/25/2007 | WO2007009774A1 Benzimidazole derivatives for treatment of inflammatory diseases |
| 01/25/2007 | WO2007009773A1 Pyrazolo[1.5-a]pyrimidin-7-yl amine derivatives as protein kinase inhibitors |
| 01/25/2007 | WO2007009772A1 Thiocolchicoside analogues with myorelaxant and anti-inflammatory activity |
| 01/25/2007 | WO2007009769A1 Oral contraception with trimegestone |
| 01/25/2007 | WO2007009757A1 Purine derivatives as agonists of the adenosine a2a receptor |
| 01/25/2007 | WO2007009742A1 Low-glycemic mixtures |
| 01/25/2007 | WO2007009741A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists |
| 01/25/2007 | WO2007009739A1 Compounds |
| 01/25/2007 | WO2007009734A2 Combination preparation, particularly for treating prostate cancer |
| 01/25/2007 | WO2007009724A2 Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009723A2 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009722A1 Octahydropentalene-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009721A2 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009720A2 Prodrugs of pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009715A1 2-cyano-pyrimidines and -triazines as cysteine protease inhibitors |
| 01/25/2007 | WO2007009712A1 Indoline-substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009709A1 Cycloalkane-substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009708A1 Salts of substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009707A2 Use of substituted pyrazoline compounds for the treatment of coagulation related diseases |
| 01/25/2007 | WO2007009705A1 (rac)-n-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydr0-1h-pyrazole-3-carboxamide hydrates |
| 01/25/2007 | WO2007009700A2 Use of substituted pyrazoline compounds for the treatment of the lipid parameters of the metabolic syndrome |
| 01/25/2007 | WO2007009698A1 Combination of pyrazoline type cannabinoid receptor antagonist and statin |
| 01/25/2007 | WO2007009697A1 Quaternary ammonium salts of substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009696A1 Use of substituted pyrazoline compounds for the preparation of paediatric medicaments |
| 01/25/2007 | WO2007009695A1 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009694A1 Use of substituted pyrazoline compounds for the preparation of medicaments for the treatment of metabolic syndrome |
| 01/25/2007 | WO2007009693A1 Combination of a substituted pyrazoline compound and a drug used in food-related disorders |
| 01/25/2007 | WO2007009692A1 Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes |
| 01/25/2007 | WO2007009691A2 Combination of substituted pyrazolines and anti -addictive agent |
| 01/25/2007 | WO2007009690A1 Heterocyclyl-substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009689A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009688A1 Thiocarbonyl-substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 01/25/2007 | WO2007009687A1 Carbonyl substituted pyrazoline compounds, their preparation and use as cb1 receptor modulators |
| 01/25/2007 | WO2007009683A2 Pharmaceutical formulations of substituted pyrazoline compounds |